Anaplastic thyroid cancer (ATC) has proven very difficult to research due to a combination of its rarity and the associated short survival period for many of those affected. Estimates of anaplastic thyroid cancer incidence vary and are often quoted as being between 1.5 and 5% of the total thyroid cancer patient population or representing 1-2 cases per million of the population.
This website has been developed in order to increase awareness of this rare cancer and to promote the iNATT project and any other research opportunities in this field. If you are a clinician, researcher or thyroid cancer patient support organisation and wish to have your work included on the website please contact firstname.lastname@example.org
Due to the rarity of the disease it is very difficult for a single cancer centre or cancer network to undertake research into anaplastic thyroid cancer because of the small numbers of patients diagnosed.
The iNATT project is collecting tissue, blood and clinical data from patients with anaplastic thyroid cancer in order to facilitate research opportunities.
The iNATT project is being carried out in collaboration with national and international colleagues to increase the numbers of patients who are eligible to participate.